CoChat
Sign Up
Cited by 142Heart Failure Treatment and ManagementHeart rate and cardiovascular healthCardiovascular and exercise physiology

The DOI matches its Crossref record; 108 of the 111 references it cites were found in a registry or an index.

Successes and failures of current treatment of heart failure

Cleland, John GF, Swedberg, Karl, Poole-Wilson, Philip A·1998·The Lancet
DOI 10.1016/s0140-6736(98)90015-0
Open this paper in CoChat — free account

Overview

Integrity signals

Registry

Crossref · 10.1016/s0140-6736(98)90015-0

Cites

108 of 108 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 111 references

Research works printed but not linked: 15

  1. Remme, 1997, European Society of Cardiology: guidelines for the management of heart failure, Eur Heart J, 18, 736
  2. Cleland, 1998, Health economic and quality of life issues in heart failure, Eur Heart J
  3. Sherman, 1995, Piretanide, a potent diuretic with potassium-sparing properties, for the treatment of congestive heart failure: an epidemiologic perspective, J Am Coll Cardiol, 26, 1565
  4. Lewis, 1991, Double-blind comparison of high-dose bumetanide and half-dose bumetanide together with captopril in heart failure, Curr Ther Res Clin Exp, 50, 3
  5. Murray, 1998, Decreased hospitalisation for CHF by using a completely and predictably absorbed loop diuretic, J Am Coll Cardiol, 31, 465C
  6. Abraham, 1997, Effects of an oral, nonpeptide, selective V2 receptor vasopressin antagonist in patients with chronic heart failure, J Am Coll Cardiol, 29, 169A
  7. Gheorghiade, 1995, The effects of digoxin withdrawal in patients with stable heart failure due to coronary artery disease compared to primary cardiomyopathy; insights from the PROVED and RADIANCE studies, Circulation, 92, I, 142
  8. Fowler, 1997, Comparison of high versus low-dose enalapril therapy on clinical outcomes and neuroendocrine activation in advanced heart failure, Circulation, 96, I, 20
  9. Klinger, 1997, Effects of losartan on exercise capacity, morbidity and mortality in patients with symptomatic heart failure, JACC, 29, 205A
  10. Herlitz, 1996, Effect of metoprolol among patients with suspected acute myocardial infarction and left ventricular dysfunction, Eur Heart J, 17, 514
  11. Louie, 1991, 84, 290
  12. 1997, 337, 1576
  13. Pedersen, 1997, Trandolapril reduces the incidence of atrial fibrillation following acute myocardial infarction, Circulation, 96, I, 75
  14. Deedwania, 1996, Amiodarone improves survival by restoring and maintaining sinus rhythm in patients with chronic atrial fibrillation, dialted cardiomyopathy, and congestie heart failure, Circulation, 94, I, 663
  15. Kjekshus, 1997, The effects of simvastatin on the incidence of heart failure patients with coronary heart disease, J Card Fail, 3, 249, 10.1016/S1071-9164(97)90022-1 · DOI · Paper page

Cited by

Sorted by citations

See all 142

Related

Metadata

Authors
Cleland, J. G., Swedberg, K., & Poole-Wilson, P. A.
Affiliations
  • University of Glasgow (GB)
  • Imperial College London (GB)
Corresponding author
Cleland, John GF
ORCID
Venue
The Lancet
Publisher
Elsevier BV
Published
1998-08
Volume
352
Pages
SI19-SI28
ISSN
  • 0099-5355 (ISSN-L)
  • 0140-6736
DOI
10.1016/s0140-6736(98)90015-0
OpenAlex
W2075926626
Cited by
141
References
111
Citations by year
2026: 1 · 2025: 2 · 2022: 3 · 2020: 2 · 2019: 1 · 2018: 4 · 2017: 2 · 2016: 3 · 2014: 1 · 2013: 5 · 2012: 2
FWCI
3.10
Type
journal article
Language
en
Open access
closed
Licence
www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Locations
  • The Lancet (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Heart Failure Treatment and Management
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Heart rate and cardiovascular health
  • Health Sciences › Medicine › Physiology (medical) › Cardiovascular and exercise physiology
Keywords
heart failure, heart failure treatment, exercise capacity, hemodynamics, symptom improvement, surrogate endpoints, clinical trial endpoints, drug approval
MeSH terms
Cardiac Output, Low, Clinical Trials as Topic, Humans, Prognosis, Treatment Outcome

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review